Department of Pathophysiology, School of Basic Medicine, Tongji Medical College; Institute of Brain Research; Key Laboratory of Neurological Diseases, Ministry of Education; Hubei Provincial Key Laboratory of Neurological Diseases, Huazhong University of Science and Technology, Wuhan, China.
Department of Urology, Union Hospital, Huazhong University of Science and Technology, Wuhan, China.
Cell Death Dis. 2018 Feb 7;9(2):163. doi: 10.1038/s41419-017-0260-8.
Cerebral ischemia causes severe cell death or injury including axon breakdown or retraction in the brain. Axon regeneration is crucial for the functional recovery of injured neurons or brains after ischemia/reperfusion (I/R); however, this process has been proved extremely difficult in adult brains and there is still no effective therapy for it. Here we reported that neuroglobin (Ngb), a novel oxygen-binding or sensor protein existing predominantly in neurons or brains, functions as a driving factor for axon regeneration during I/R. Ngb was upregulated and accumulated in growth cones of ischemic neurons in primary cultures, rat, and human brains, correlating positively to the elevation of axon-regeneration markers GAP43, neurofilament-200, and Tau-1. Ngb overexpression promoted while Ngb knockdown suppressed axon regeneration as well as GAP43 expression in neurons during oxygen-glucose deprivation/reoxygenation (OGD/Re). By using specific pharmacological inhibitors, we identified p38 MAPK as the major downstream player of Ngb-induced axon regeneration during OGD/Re. Mechanistically, Ngb directly bound to and activated p38 in neurons upon OGD/Re. Serial truncation and point mutation of Ngb revealed that the 7-105 aa fragment of Ngb was required and the oxygen-binding site (His) of Ngb was the major regulatory site for its p38 interaction/activation. Finally, administration of exogenous TAT-Ngb peptides significantly enhanced axon regeneration in cultured neurons upon OGD/Re. Taken together, Ngb promotes axon regeneration via O-Ngb-p38-GAP43 signaling during I/R. This novel mechanism suggests potential therapeutic applications of Ngb for ischemic stroke and other related axonopathy.
脑缺血导致严重的细胞死亡或损伤,包括轴突断裂或回缩。轴突再生对于缺血/再灌注(I/R)后受损神经元或大脑的功能恢复至关重要;然而,在成人大脑中,这一过程被证明极其困难,目前仍然没有有效的治疗方法。在这里,我们报道了神经球蛋白(Ngb),一种主要存在于神经元或大脑中的新型氧结合或传感器蛋白,作为 I/R 期间轴突再生的驱动因素。在原代培养物、大鼠和人脑的缺血神经元的生长锥中,Ngb 上调并积累,与轴突再生标志物 GAP43、神经丝-200 和 Tau-1 的升高呈正相关。Ngb 过表达促进,而 Ngb 敲低抑制神经元在氧葡萄糖剥夺/再氧合(OGD/Re)期间的轴突再生和 GAP43 表达。通过使用特异性药理学抑制剂,我们确定 p38 MAPK 是 Ngb 在 OGD/Re 期间诱导轴突再生的主要下游靶点。在机制上,Ngb 在 OGD/Re 后直接与神经元上的 p38 结合并激活它。Ngb 的串联截断和点突变表明,Ngb 的 7-105 aa 片段是必需的,并且 Ngb 的氧结合位点(His)是其与 p38 相互作用/激活的主要调节位点。最后,外源性 TAT-Ngb 肽的给药显著增强了 OGD/Re 后培养神经元中的轴突再生。总之,Ngb 通过 I/R 期间的 O-Ngb-p38-GAP43 信号促进轴突再生。这种新的机制为 Ngb 治疗缺血性中风和其他相关轴突病提供了潜在的治疗应用。